Login / Signup

The Relevance of REMAP-ILD for Ibero-American Countries: A Randomized Embedded Multifactorial Adaptive Platform (REMAP) Trial in the Field of Interstitial Lung Diseases (ILDs).

Leticia Kawano-DouradoMaria Molina-MolinaJacobo SellaresJuan I Enghelmayer
Published in: Archivos de bronconeumologia (2024)
Keyphrases
  • interstitial lung disease
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • high throughput
  • systemic sclerosis
  • randomized controlled trial
  • rheumatoid arthritis
  • open label